We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AFA Denounces FDA’s Approval of Newborn Stem Cell Experimentation
News

AFA Denounces FDA’s Approval of Newborn Stem Cell Experimentation

AFA Denounces FDA’s Approval of Newborn Stem Cell Experimentation
News

AFA Denounces FDA’s Approval of Newborn Stem Cell Experimentation

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AFA Denounces FDA’s Approval of Newborn Stem Cell Experimentation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AFA further denounces the FDA, Cord Blood Registry ®, LSL/AVT specialists, Children’s Memorial Hospital (Houston), and the principal investigators of this study for undermining the human rights of their patients and promoting eugenic outcomes.

The newswire released on January 12, 2012 from Cord Blood Registry® and Children’s Memorial Hermann Hospital states that parents of newborns and infants between six weeks to 18 months will be recruited.  The infants will undergo MRIs (which frequently include sedation), blood tests, and be given their own stored stem cord blood via IV infusions.  Possible health risks to the infant were not mentioned. (see http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss)

The newswire contained alarmist views of how being Deaf impacts language abilities and social development without describing research concerning the negative impact of withholding American Sign Language and access to cultural identification with other Deaf people.

When contacted, Dr. Harlan Lane, Distinguished Professor at Northeastern University and recipient of the MacArthur Genius Award stated:  “Children who are born Deaf or early become so have a dual heritage – they have their parents’ ethnicity and also that of the sign language minority; their natural language is American Sign Language.   Exclusively pathological views of Deaf children have been out of date for decades. Deaf babies are healthy babies and live fulfilling and contributing lives.”

AFA advocates for the rights of Deaf Americans, cultural resurgence, and seeks primarily to challenge the ideological foundations of audism in America. Audism is attitudes and practices based on the assumption that behaving in the ways of those who speak and hear is desired and best. It produces a system of privilege, thus resulting in stigma, bias, discrimination, and prejudice—in overt or covert ways—against Deaf culture, American Sign Language, and Deaf people of all walks of life.

AFA calls upon governmental agencies to ensure their commitment to protecting all citizens, including Deaf newborns and infants. The actions by the FDA serve to highlight the medical community’s systematic effort to threaten the culture, language, and right to life of Deaf people—and therefore, endangering linguistic and cultural diversity in the United States.

Advertisement